Activity

Filter

Cancel
Date Panel Item Activity
6 actions
Genomic newborn screening: BabyScreen+ v1.144 RBM20 Zornitza Stark Marked gene: RBM20 as ready
Genomic newborn screening: BabyScreen+ v1.144 RBM20 Zornitza Stark Gene: rbm20 has been classified as Amber List (Moderate Evidence).
Genomic newborn screening: BabyScreen+ v1.144 RBM20 Zornitza Stark Phenotypes for gene: RBM20 were changed from Cardiomyopathy, dilated, 1DD to Cardiomyopathy, dilated, 1DD, MIM# 613172 AD
Genomic newborn screening: BabyScreen+ v1.143 RBM20 Zornitza Stark changed review comment from: DEFINITIVE association with DCM. Not assessed for actionability by ClinGen yet.; to: DEFINITIVE association with DCM. Not assessed for actionability by ClinGen yet. Not suitable for gNBS.
Genomic newborn screening: BabyScreen+ v1.143 RBM20 Zornitza Stark reviewed gene: RBM20: Rating: AMBER; Mode of pathogenicity: None; Publications: ; Phenotypes: Cardiomyopathy, dilated, 1DD, MIM# 613172 AD; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Genomic newborn screening: BabyScreen+ v0.0 RBM20 Zornitza Stark gene: RBM20 was added
gene: RBM20 was added to gNBS. Sources: Expert Review Amber,BabySeq Category B gene
Mode of inheritance for gene: RBM20 was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Phenotypes for gene: RBM20 were set to Cardiomyopathy, dilated, 1DD